Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors (Q40343408)

From Wikidata
Jump to navigation Jump to search
scientific article published on March 2006
edit
Language Label Description Also known as
English
Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors
scientific article published on March 2006

    Statements

    Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors (English)
    0 references
    0 references
    Malcolm Ranson
    Mark R Middleton
    John Bridgewater
    Debra Jowle
    Gavin Halbert
    Sue Waller
    Helen McGrath
    Lindsey Gumbrell
    R Stanley McElhinney
    Dorothy Donnelly
    T Brian H McMurry
    Geoffrey P Margison
    1 March 2006
    1577-1584

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit